Showing results (3611-3620 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|January 21, 2018
Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor SurvivorsMichal Chovanec, Lucia Vasilkova, Lucia Setteyova, et al.
The Oncologist|January 4, 2019
Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5-Year Follow-upRui Wang, Lillian M Smyth, Neil Iyengar, et al.
The Oncologist|January 4, 2019
Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor TherapySantiago Cabezas-Camarero, Virginia de la Orden García, Vanesa García-Barberán, et al.
The Oncologist|March 24, 2018
Costs of Cancer Care Across the Disease ContinuumDeborah R Kaye, Hye Sung Min, Lindsey A Herrel, et al.
The Oncologist|March 24, 2018
Families' Sense of Abandonment When Patients Are Referred to HospiceTakuya Odagiri, Tatsuya Morita, Maho Aoyama, et al.
The Oncologist|March 24, 2018
Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International ComparisonNina C A Vermeer, Yvette H M Claassen, Marloes G M Derks, et al.
The Oncologist|January 11, 2019
Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma GroupGabriel G Malouf, Guillaume Beinse, Julien Adam, et al.
The Oncologist|January 18, 2019
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II TrialAkira Nakao, Osamu Hiranuma, Junji Uchino, et al.
The Oncologist|January 20, 2019
Numbers Have Life: A Commentary on "Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit"Jennifer G Le-Rademacher, Aminah Jatoi
The Oncologist|December 19, 2018
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision AnalysisJin G Choi, Ryan D Nipp, Angela Tramontano, et al.
Pageof 571